本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tiziana Life Sciences PLC

1.13
+0.06005.61%
盘后1.07-0.0599-5.30%18:03 EDT
成交量:30.84万
成交额:33.92万
市值:1.23亿
市盈率:-8.47
高:1.14
开:1.07
低:1.01
收:1.07
数据加载中...
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/02/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/02/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/20

[补充]招股说明书

Filing under Securities Act Rules 163/433 of free writing prospectuses
2019/09/20

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/09/17

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers